IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

VILLA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.489
AS - Asia 9.360
EU - Europa 9.279
SA - Sud America 904
AF - Africa 268
OC - Oceania 69
Continente sconosciuto - Info sul continente non disponibili 13
AN - Antartide 1
Totale 29.383
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.147
CN - Cina 2.998
SG - Singapore 2.723
GB - Regno Unito 2.705
IT - Italia 2.266
RU - Federazione Russa 850
HK - Hong Kong 788
DE - Germania 772
SE - Svezia 738
BR - Brasile 692
IN - India 662
VN - Vietnam 500
FR - Francia 390
BD - Bangladesh 313
KR - Corea 302
NL - Olanda 291
TR - Turchia 263
IE - Irlanda 258
JP - Giappone 255
FI - Finlandia 227
CA - Canada 197
UA - Ucraina 165
ID - Indonesia 154
DK - Danimarca 139
MX - Messico 90
CI - Costa d'Avorio 75
PL - Polonia 71
AU - Australia 63
EU - Europa 63
BE - Belgio 58
AR - Argentina 52
PK - Pakistan 51
CO - Colombia 50
AT - Austria 48
CZ - Repubblica Ceca 47
ZA - Sudafrica 44
IQ - Iraq 43
CH - Svizzera 42
ES - Italia 42
EG - Egitto 38
TW - Taiwan 36
IR - Iran 35
PH - Filippine 35
EC - Ecuador 31
CL - Cile 28
GR - Grecia 27
MY - Malesia 27
PE - Perù 27
TH - Thailandia 26
SA - Arabia Saudita 24
PT - Portogallo 21
UZ - Uzbekistan 18
RO - Romania 17
SK - Slovacchia (Repubblica Slovacca) 17
MA - Marocco 15
NG - Nigeria 15
BY - Bielorussia 13
IL - Israele 13
AE - Emirati Arabi Uniti 11
AZ - Azerbaigian 11
KE - Kenya 11
CR - Costa Rica 10
DZ - Algeria 10
JM - Giamaica 10
JO - Giordania 10
TN - Tunisia 10
VE - Venezuela 10
HU - Ungheria 9
NP - Nepal 9
PY - Paraguay 9
RS - Serbia 9
BG - Bulgaria 8
NO - Norvegia 8
LV - Lettonia 7
SD - Sudan 7
ET - Etiopia 6
GH - Ghana 6
LT - Lituania 6
SC - Seychelles 6
SI - Slovenia 6
SN - Senegal 6
AL - Albania 5
KG - Kirghizistan 5
LB - Libano 5
LU - Lussemburgo 5
NZ - Nuova Zelanda 5
PA - Panama 5
PR - Porto Rico 5
A1 - Anonimo 4
GE - Georgia 4
HN - Honduras 4
KW - Kuwait 4
MD - Moldavia 4
TT - Trinidad e Tobago 4
YE - Yemen 4
AO - Angola 3
BA - Bosnia-Erzegovina 3
BO - Bolivia 3
GT - Guatemala 3
KZ - Kazakistan 3
Totale 29.370
Salva come PNG Salva come JPEG
Città #
Southend 2.306
Singapore 1.610
Ashburn 1.009
Milan 906
Hong Kong 661
Chandler 564
San Jose 558
Dallas 546
Beijing 528
Fairfield 367
Seattle 363
Ann Arbor 341
Santa Clara 309
Council Bluffs 307
Wilmington 307
Hefei 276
Princeton 262
Los Angeles 249
Dublin 247
Woodbridge 208
Bengaluru 173
New York 163
Ho Chi Minh City 152
Lauterbourg 152
Houston 150
Cambridge 141
Hanoi 138
Guangzhou 137
Moscow 135
Frankfurt am Main 134
Dearborn 123
Redwood City 122
Buffalo 121
Shanghai 120
Nanjing 116
Helsinki 104
Munich 100
Tokyo 96
Seoul 95
Mountain View 90
Boardman 89
The Dalles 88
Des Moines 84
Jakarta 83
Redmond 79
Abidjan 74
Columbus 73
Shenyang 72
Pavia 71
Rome 71
Phoenix 70
Istanbul 68
Jacksonville 65
São Paulo 59
Tianjin 58
Jinan 56
Cangzhou 54
Berlin 50
Medford 49
Sakarya 47
Ottawa 46
Serra 45
Somerville 45
Chicago 44
Delhi 44
Brussels 43
Changsha 41
Orem 41
London 38
Toronto 38
Nuremberg 37
Piscataway 37
Wuhan 37
Hangzhou 36
San Genesio ed Uniti 36
Andover 35
Shenzhen 35
Hyderabad 34
Rio de Janeiro 34
San Diego 34
Warsaw 34
Bogotá 33
Kent 32
Segrate 32
Boston 31
Glasgow 31
Chennai 29
Fuzhou 29
Amsterdam 28
Turin 28
Montreal 27
Mumbai 26
Nanchang 26
Naples 26
Eitensheim 25
Florence 25
Grafing 25
Zhengzhou 25
Vienna 24
Brooklyn 23
Totale 17.185
Salva come PNG Salva come JPEG
Nome #
An Overview on the Potential Antimycobacterial Agents Targeting Serine/Threonine Protein Kinases from Mycobacterium tuberculosis 670
Signal Transducer and Activator of Transcription Protein 3 (STAT3) : an Update on its Direct Inhibitors as Promising Anticancer Agents 656
The response of Escherichia coli biofilm to salicylic acid 524
Structure-based drug design, synthesis and biological assays of P. falciparum Atg3-Atg8 protein-protein interaction inhibitors 467
An in vivo active 1,2,5-oxadiazole Pt(II) complex : a promising anticancer agent endowed with STAT3 inhibitory properties 421
Synthesis of new dithiolethione and methanethiosulfonate systems endowed with pharmaceutical interest 414
Natural products against key Mycobacterium tuberculosis enzymatic targets : Emerging opportunities for drug discovery 379
Synthesis, structure–activity relationships andstereochemical investigations of new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 367
Discovery and development of novel salicylate synthase (MbtI) Furanic inhibitors as antitubercular agents 357
Unravelling the Structural and Molecular Basis Responsible for the Anti-Biofilm Activity of Zosteric Acid 317
Modeling, synthesis and NMR characterization of novel chimera compounds targeting STAT3 306
Sub-lethal Activity of Small Molecules from Natural Sources and their Synthetic Derivatives Against Biofilm Forming Nosocomial Pathogens 280
Low density polyethylene functionalized with antibiofilm compounds inhibits Escherichia coli cell adhesion 274
6-Hydroxy-2-methylbenzofuran-4-carboxylic acid 271
New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents 262
Evaluation of anti-prion activity of Congo Red and its derivatives in experimentally infected hamsters 257
Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents 257
Exploring molecular targets and pathways involved in the antibiofilm activity of zosteric acid related structure by a multi-strategy proteomic approach 255
Structural basis for specific inhibition of salicylate synthase from Mycobacterium abscessus 254
Modeling and Spectroscopic Studies of Synthetic Diazabicyclo Analogs of the HIV-1 Inhibitor BMS-378806 and Evaluation of Their Antiviral Activity 253
Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria 251
Investigating the inhibition mechanism and catalytic cycle of MbtI, the salicylate synthase from Mycobacterium tuberculosis 249
Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections 248
Natural compounds targeting E. Coli WRBA as antibiofilm agents: Virtual screening, design and synthesis of analogs, biological evaluation 245
Behaviour of 5,6-dihydrothieno[2,3-h]cinnolin-3(2H)-one and 5,6-dihydrothieno[3,2-h]cinnolin-3(2H)-one towards hydrazine. Synthesis of thienocinnolinones and of 4-aminothienocinnolinones 244
Biological and computational evaluation of an oxadiazole derivative (MD77) as a new lead for direct STAT3 inhibitors 242
ANFOMAT - Novel materials for medical devices based on biofunctionalized surfaces with antifouling properties 241
Crystal structure of 3-(3-oxo-2,3,4,4a,5,6-hexahydrobenzo[h]cinnolin-2-yl)propionic acid 239
Anti-biofilm efficacy of novel silica-based nanoparticles functionalized withnatural derivatives for surface coating 235
Shedding X-ray light on the role of magnesium in the activity of M. tuberculosis salicylate synthase (MbtI) for drug design 233
Synthesis and biological activity of new antiviral compounds 230
Pharmacokinetics and distribution of sodium 3,4-diaminonaphtalene-1-sulfonate, a Congo Red derivative active in inhibiting PrPres replication 229
Synthesis and cytotoxic activities of 3-(5-phenyl-[1,3,4]oxadiazol-2-yl)-1H-benzo[g]indole and related compounds 225
Synthesis, Modelling, and Antimitotic Properties of Tricyclic Systems Characterised by a 2-(5-Phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole Moiety 222
Diazabicyclo analogues of maraviroc : synthesis, modeling, NMR studies and antiviral activity 222
Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for the opioid receptors 219
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 218
Benzothiadiazole derivatives endowed with STAT3 inhibition 214
New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI) : Preliminary Biological Evaluation and Molecular Modeling Studies 212
Signal transducer and activator of transcription (Stat) 3: a promising target for anticancer therapy 211
Antifouling agents : functionalization of surfaces to obtain novel medical device materials inhibiting biofilm formation 211
New inhibitors of salicylate synthase (MbtI) from m. tubercolosis: a promising strategy to antitubercular drugs 211
A field-based disparity analysis of new 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 211
Chemical behaviour and crystallographic characterization of ureido 1,2,5-oxadiazole derivatives, related to Stat3 inhibitors 209
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists 208
Structure activity relationship of zosteric acid analogues as inhibitors of biofilm formation by Escherichia coli 207
Towards the Inhibition of Protein–Protein Interactions (PPIs) in STAT3: Insights into a New Class of Benzothiadiazole Derivatives 205
Synthesis, structure-activity relationships and stereochemical investigations on new tricyclic pyridazinone derivatives as potential STAT3 inhibitors 204
Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy 201
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 200
Exploring the anti-biofilm activity of zosteric acid via high-throughput screening of a small molecules scaffold-based library 200
Synthesis, modeling, and crystallographic study of 3,4-disubstituted-1,2,5-oxadiazoles and evaluation of their ability to decrease STAT3 activity 198
Studies on potential STAT-3 inhibitors: reactivity and behaviour of furazan derivatives 198
Unravelling the Antiproliferative Activity of 1,2,5-oxadiazole Derivatives 197
Exploring the Inhibition of Iron Acquisition in M. abscessus as a Potential Anti-Virulence Strategy in People with Cystic Fibrosis 193
Ironing out Fe3+ acquisition in M. abscessus: a new strategy to target virulence factors in non-tuberculous mycobacteria 192
3,8-diazabicyclo[3.2.1]octane derivatives as analogues of abasilide, a class III antiarrhythmic agent 192
Novel peptidomimetics related to Gonadotropin releasing hormone (GnRH) 192
3-(5-phenyl-[1,3,4]oxadiazol-2-yl)-1H-benzo[g]indole and related compounds : synthesis and cytotoxic activities 191
An Outline of the Latest Crystallographic Studies on Inhibitor-Enzyme Complexes for the Design and Development of New Therapeutics against Tuberculosis 191
Ureido-pyridazinone derivatives : insights into the structural and conformational properties for STAT3 inhibition 188
Zosteric acid and salicylic acid bound to a low density polyethylene surface successfully control bacterial biofilm formation 188
Merged structures as new STAT3 inhibitors: the chimera compounds 187
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation 186
SYNTHESIS, COMPUTATIONAL STUDIES AND HIV-1 NEUTRALIZATION ASSAY OF NOVEL MARAVIROC RELATED COMPOUNDS 185
Identification of the mechanism of action of 5,6-dimethyl-1H,3H-2,1,3-benzothiadiazole-2,2-dioxide as STAT3 inhibitor 185
Unraveling the interaction mechanism of a benzothiadiazole-2.2-dioxide derivative with STAT3 : towards novel direct inhibitors 185
Targeting the mycobactin biosynthesis pathway in M. tuberculosis: a step towards the improvement of the anti-virulence activity of MbtI inhibitors 184
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists 182
Determination of sodium 3,4-diaminonaphtalene-1-sulfonate, a Congo Red derivative, in plasma and brain of hamsters by high-performance liquid chromatography after solid-phase extraction and ultraviolet absorbance 181
STAT3 direct inhibitors: from MD77 to AC33 180
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA 179
Synthesis, molecular modelling and cytotoxicity of new 1,3,4-oxadiazoles derivatives with antimitotic activity 179
Targeting iron acquisition in M. abscessus: a new strategy for the development of anti-virulence agents for cystic fibrosis patients 178
Biological Screening and Crystallographic Studies of Hydroxy γ-Lactone Derivatives to Investigate PPARγ Phosphorylation Inhibition 178
Crystallographic and docking studies on 2-(5-phenyl-1H-pyrrol-3-yl)-1,3,4-oxadiazole derivatives having antimitotic properties 178
Functionalized nanoparticles as potential antibiofilm agents 176
A dual-target approach in anti-tuberculosis therapy: new MptpB/MbtI inhibitors 174
Optimizing the drug discovery process for the development of MbtI inhibitors as promising anti-virulence agents against TB 172
An oxadiazole Pt(II) complex with promising in vivo antitumor activity 172
A hit expansion of 3-benzamidopyrazine-2-carboxamide: Toward inhibitors of prolyl-tRNA synthetase with antimycobacterial activity 172
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid 171
Development on furazan derivatives as potential STAT-3 inhibitors 169
Development of novel substituted naphthyl amino benzoic acid derivatives as CDC25 phosphatase inhibitors: design, synthesis and biological evaluation 169
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 168
Exploring the biological activity of a library of 1,2,5-oxadiazole derivatives endowed with antiproliferative activity 168
Design, synthesis and biological evaluation of novel antitubercular agents targeting the Salycilate Syntase (MbtI). 168
An exhaustive conformational evaluation of the HIV-1 inhibitor BMS-378806 through theoretical calculations and nuclear magnetic resonance spectroscopy 166
Discovery of novel SIRT5 activators as potential anti-inflammatory agents 165
Oxadiazole Pt(II) complexes: promising STAT3 inhibitors in cancer therapy 164
Design and synthesis of novel furan-based MbtI inhibitors as potential antitubercular agents 163
Eco-Friendly Bio-Based Solvents for the Acetylation of the Amino Group of Amino Acids 162
Mycobacterium tuberculosis Low Molecular Weight Phosphatases (MPtpA and MPtpB) : from Biological Insight to Inhibitors 161
Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent 161
Novel anti-biofilm materials for medical devices based on biofunctionalized surfaces 159
Mono- and disubstituted-3,8-diazabicyclo[3.2.1]octane derivatives as analgesics structurally related to epibatidine: Synthesis, activity, and modeling 158
Development of a novel approach to overcome biofilm formation by natural product derivatives 157
Complete Characterization of the 3D Properties of the CCR5 Antagonist Vicriviroc through DFT Calculations, NMR Spectroscopy, and X-ray Analysis 157
X-ray structure and chemical behaviour of three oxadiazole derivatives, as potential Stat3 inhibitors 156
Tricyclic Pyridazinone derivatives : development of new STAT-3 inhibitors 156
Totale 22.768
Salva come PNG Salva come JPEG
Categoria #
all - tutte 86.063
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.063
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021409 0 0 0 0 0 0 0 0 0 0 283 126
2021/20222.041 178 107 108 84 218 168 194 175 181 142 122 364
2022/20232.621 273 227 245 211 244 414 115 160 352 76 170 134
2023/20242.258 107 138 181 141 354 133 283 179 88 172 238 244
2024/20255.200 203 408 140 491 464 256 251 532 315 503 633 1.004
2025/20269.733 951 836 1.108 912 863 604 1.213 498 1.120 757 871 0
Totale 30.830